Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Hum Pathol. 2019 May 6;90:1–7. doi: 10.1016/j.humpath.2019.04.018

Table 3:

Pathologists report and IHC staining interpretation of BLC(+)/atypical biopsies

#1 (GU) #2 (GU) #3 (GU) #4 (GU) #5 (GRL) #6 (GRL) #7 (GRL) Total P53 CK20 Ki67 Int
C B A C B A C B A C B A C B A C B A C B A C B A
1 X X X X X X X 0 2 5 >50% S Neg 0% B
2 X X X X X X X 0 3 4 20% M Neg 2% B
3 X X X X X X X 0 3 4 10% M Neg 10% B
4 X X X X X X X 1 2 4 20% M Neg 0% B
5 X X X X X X X 1 2 4 60% M Neg 0% B
6 X X X X X X X 0 1 6 50% M Neg 0% B
7 X X X X X X X 1 1 5 50% M Neg 10% B
8 X X X X X X X 2 0 5 Den Den Den -
9 X X X X X X X 1 4 2 20% M Neg 20% B
10 X X X X X X X 6 1 0 30% M Neg 20% B
11 X X X X X X X 2 1 4 10% M Neg 0% B

A:atypical; B:benign; BLC:blue light cystoscopy; C : carcinoma in situ; Den: denudation; Int: immunohistochemistry interpretation; GU: genitourinary pathologist; GRL: general pathologist; IHC: immunohistochemistry; M:moderate; S:strong.